© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

SRI

Top section

Top section

CEB plunges into Sofr FRNs with $500m debut

New product 'ticks boxes' including more investor diversification for Paris-based supranational, which also sold its largest Kangaroo
SSA
Newfoundland prints 20 year, Crédit Agricole debuts a green covered bond

Lloyds lifts green senior euros after Yankee foray

◆ UK lender raises $4.5bn-equivalent in five senior holding company tranches this week ◆ Both deals target long dated funding ◆ Despite secondary widening, euro offering lands with hardly any premium

Crédit Agricole differentiates from competition with 'untested' 12 year SNP bullet

◆ Insurance companies anchor long dated green tranche with near-4% yield ◆ Curve extension debated ◆ Deal comes amid widening secondary spreads but lands with negligible premium
SSA
Newfoundland prints 20 year, Crédit Agricole debuts a green covered bond
Sub-sections
  • Hope of a Covid-19 vaccine ignited risk appetite for equity and corporate credit this week, as companies in struggling sectors enjoyed soaring share prices and printed bonds through fair value, write Mike Turner, Sam Kerr and Aidan Gregory.
  • Financial institutions jumped into action this week, as positive news on the development of a Covid-19 vaccine led to superlative funding conditions in the euro market.
  • The Central American Bank for Economic Integration (Cabei) said it became the first multilateral lender to sell a Covid-19 “vaccine bond” after raising $50m of five-year money to support immunisation initiatives when Covid-19 vaccine becomes available.